4//SEC Filing
Ehrlich Christopher B 4
Accession 0000950170-24-073204
CIK 0001828522other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:25 PM ET
Size
5.6 KB
Accession
0000950170-24-073204
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-06-13+800→ 800 totalExercise: $1.38Exp: 2034-06-12→ Common Stock (800 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001293973
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:25 PM ET
- Size
- 5.6 KB